Inozyme Pharma Inc. (INZY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inozyme Pharma Inc.

    NASDAQ: INZY · Real-Time Price · USD
    4.00
    0.00 (0.00%)
    At close: Jun 30, 2025, 3:59 PM

    Inozyme Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 21.08M 34.59M 32.91M 23.32M
    Short-Term Investments
    		 92.01M 154M 94.95M 88.48M
    Long-Term Investments
    		 n/a n/a 354K 354K
    Other Long-Term Assets
    		 1.16M 2M 3.81M 3.41M
    Receivables
    		 467K 385K 115K 62K
    Inventory
    		 n/a n/a -115K -62K
    Other Current Assets
    		 311K n/a n/a n/a
    Total Current Assets
    		 120.68M 196.25M 131.39M 115.34M
    Property-Plant & Equipment
    		 1.35M 2.59M 3.64M 4.44M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 2.51M 4.6M 7.8M 8.2M
    Total Assets
    		 123.18M 200.85M 139.19M 123.54M
    Account Payables
    		 2.53M 1.17M 2.54M 2.39M
    Deferred Revenue
    		 n/a n/a 3.81M n/a
    Short-Term Debt
    		 15.41M n/a 816K 731K
    Other Current Liabilities
    		 12.29M 8.77M 7.74M 5.4M
    Total Current Liabilities
    		 33.9M 14.69M 14.71M 11.63M
    Long-Term Debt
    		 31.46M 44.77M 4.14M n/a
    Other Long-Term Liabilities
    		 n/a n/a 124K n/a
    Total Long-Term Liabilities
    		 31.46M 45.68M 6.09M 2.64M
    Total Liabilities
    		 65.36M 60.37M 20.8M 14.27M
    Total Debt
    		 46.87M 46.59M 6.78M 3.37M
    Book Value
    		 57.83M 140.48M 118.39M 109.27M
    Book Value Per Share
    		 0.92 2.71 3.14 4.64
    Common Stock
    		 6K 6K 4K 2K
    Retained Earnings
    		 -387.95M -285.93M -214.76M -147.7M
    Comprehensive Income
    		 69K 41K -205K 18K
    Shareholders Equity
    		 57.83M 140.48M 118.59M 109.27M
    Total Investments
    		 92.01M 154M 94.95M 88.48M

    Add to Watchlist